Furthermore, codon-optimized RhCEA cDNA (rhCEAopt) was demonstrated to have higher immune reactivity than hCEAopt in mice [352], Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients [353]. The gene discussed is ERBB2; the disease is cancer.